by Aya Gonzalez
Dec 02, 2020Numinus Wellness Inc. and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) have teamed up to petition Health Canada for approval to begin a trial using MDMA to treat PTSD.
If approval is granted, this will be the first trial of its kind on Canadian soil. Numinus’ Vancouver clinic will host the study, beginning with 20 people who experience treatment-resistant symptoms of PTSD.
